EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

Basit Öğe Kaydı
dc.contributor.authorŞendur, Mehmet Ali Nahit
dc.contributor.authorAksoy, Sercan
dc.contributor.authorUncu, Doğan
dc.contributor.authorDemir, H.
dc.contributor.authorYuksel, S.
dc.contributor.authorEkinci, Ahmet Siyar
dc.contributor.authorKaplan, A.
dc.date.accessioned2020-03-26T18:50:25Z
dc.date.available2020-03-26T18:50:25Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description39th ESMO Congress (ESMO) -- SEP 26-30, 2014 -- Madrid, SPAINen_US
dc.description.abstract[Abstract not Available]en_US
dc.description.sponsorshipESMOen_US
dc.identifier.doi10.1093/annonc/mdu327.44en_US
dc.identifier.issn0923-7534en_US
dc.identifier.issn1569-8041en_US
dc.identifier.urihttps://dx.doi.org/10.1093/annonc/mdu327.44
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30807
dc.identifier.volume25en_US
dc.identifier.wosWOS:000346901000167en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.relation.ispartofANNALS OF ONCOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleEFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCERen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu